Are you or someone you know experiencing early changes in memory or thinking? Do you want to learn how to keep your brain healthy or reduce your risk of developing dementia? If so, join Isaac Health and the Alzheimer’s Association for a presentation on early detection of dementia by Dr. Joel Salinas, Founder & CMO …
Are you aware of the impact that microstress is having on your daily life and overall health? Most of us know the effects of stress in general, but microstress can be more insidious, creeping into our lives unnoticed, and building up over time. In their upcoming book, “The Microstress Effect: How Little Things Pile Up …
Resources for caregivers abound – if you know where to find them. Finding the right resources for you can start with a simple systematic and persistent approach that begins with diving into the bigger hubs and directories for these resources.
Compared to caregiving for a person without dementia, caregivers of a loved one with dementia are two times more likely to experience severe financial difficulties – 70% of total lifetime costs of caring for someone with dementia is borne by families.
With new Alzheimer’s drugs like lecanemab and more on the horizon, there are outstanding questions that need to be considered by clinicians, patients, and families.
Quality of life can be improved for patients and families through comprehensive dementia care
January 9th, 2023 — The US Food and Drug Administration (FDA) has recently approved amyloid-targeting drug Leqembi (lecanemab) for the treatment of early stage Alzheimer’s disease. This is a historic development for those affected by this debilitating disease and their loved ones. Lecanemab demonstrated promising results in clinical trials, with patients experiencing a 27 percent …
Last month, the Isaac Health team had the pleasure of attending and walking in the Walk to End Alzheimer’s in Manhattan.
On September 27, 2022, drug companies Biogen and Eisai released results of the CLARITY AD phase 3 trial of a new drug that may be a potential treatment for Alzheimer’s disease: lecanemab. The trial included patients that represented the typical US population of older adults and focused on understanding whether this drug works in people …
ORLANDO September 29, 2022 — Isaac Health has been selected for the 2022 Best of Orlando Award in the Neurologist category by the Orlando Award Program. Each year, the Orlando Award Program identifies companies that we believe have achieved exceptional marketing success in their local community and business category. These are local companies that enhance …
Isaac Health Receives 2022 Best of Orlando Award Read More »
